CN103698416B - Determination method of contents of saccharate and saccharic acid 1,4-lactone in Liuwei Dihuang preparations - Google Patents

Determination method of contents of saccharate and saccharic acid 1,4-lactone in Liuwei Dihuang preparations Download PDF

Info

Publication number
CN103698416B
CN103698416B CN201310431091.XA CN201310431091A CN103698416B CN 103698416 B CN103698416 B CN 103698416B CN 201310431091 A CN201310431091 A CN 201310431091A CN 103698416 B CN103698416 B CN 103698416B
Authority
CN
China
Prior art keywords
phase
lactone
hilic
liuwei dihuang
glucarate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310431091.XA
Other languages
Chinese (zh)
Other versions
CN103698416A (en
Inventor
谢宝刚
张宁宁
姚艳琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ruijin Hongdu Industrial Investment Development Co Ltd
Original Assignee
Nanchang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanchang University filed Critical Nanchang University
Priority to CN201310431091.XA priority Critical patent/CN103698416B/en
Publication of CN103698416A publication Critical patent/CN103698416A/en
Application granted granted Critical
Publication of CN103698416B publication Critical patent/CN103698416B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of pharmaceutical analysis, and relates to a determination method of contents of saccharate and saccharic acid 1,4-lactone, two newly-discovered pharmacologically-active components, in Chinese patent medicine Liuwei Dihuang series preparations. According to the invention, saccharic acid (saccharate) and (or) saccharic acid 1,4-lactone in Liuwei Dihuang preparations are extracted by a Na2CO3 solution or a 60% methanol solution. The two compounds are analyzed quantitatively by separating detection technologies such as hydrophilic chromatography HPLC-HILIC-UV/ELSD/MS, and the like. The invention establishes the determination method of contents of saccharate and its lactone in Liuwei Dihuang preparations for the first time, and provides a new thinking and method for quality control of Liuwei Dihuang preparations.

Description

Glucarate and glucaric acid Isosorbide-5-Nitrae lactone content assay method in Liuwei Dihuang preparation
Technical field
The present invention relates to Pharmaceutical Analysis field, particularly the content assaying method of glucarate and glucaric acid Isosorbide-5-Nitrae lactone in six drugs containing rehmanniae preparation series.
Background technology
Liuwei Dihuang Wan by the 6 taste Chinese medicines such as prepared rhizome of rehmannia, the fruit of medicinal cornel, Chinese yam, rhizoma alismatis, moutan bark, Poria cocos according to a certain percentage compatibility form, the clinical practice history of existing centuries is the classics recipe of traditional Chinese medicine.Along with deepening continuously of clinical research, it cures mainly and is also extended to inside and outside, woman, youngster, face Deng Ge section by original pediatric drugs, relates to illness and has reached more than 40 and plant, have good curative effect especially to complicated chronic disease etc.Due to this patent medicine determined curative effect, almost there is no Reporting of harms, and the factor such as cheap, dark in popular favor.At present, about there are upper hundred manufacturer production six drugs containing rehmanniae products at home, mainly contain decoction, pill, oral liquid and capsule etc.; Have tens six drugs containing rehmanniae brands, annual sales amount, more than 1,000,000,000 yuan, has good Social benefit and economic benefit.
The methods such as applied chemistry and pharmacology combine, serum drug chemistry are to the pharmacological component of Liuwei Dihuang Wan, enter blood and internal metabolism composition etc. and carry out comparatively deep research, separation has obtained some bioactive polysaccharide or small molecule metabolite, achieves gratifying achievement.Metabolism group (metabonomics) is new ' group is learned ' technology occurred after genomics, transcriptomics and proteomics, under the condition mainly biosome stimulated at pathologic, physiologic, in the change of different time, multi-faceted quantitative its metabolite content of detection, inquire into and intervene thing to the subject of the regulatory mechanism of body.In recent years, metabolism group in discovery to medical diagnosis on disease, treat that relevant metabolic marker thing is studied, all have a wide range of applications in medicine effect and toxicity assessment, mechanism of action etc., demonstrate huge potentiality.We are on the basis of identifying based on HPLC-UV metabolism group Characteristic chromatographic peak, by the relative variation relation to 4 Characteristic chromatographic peaks, infer that Liuwei Dihuang Wan may affect the activity of beta-glucuronidase enzyme in rat body.Confirm that Liuwei Dihuang Wan has obvious beta-glucuronidase enzyme inhibition through experiment in vivo and vitro, thus found an action target spot---the beta-glucuronidase enzyme of Liuwei Dihuang Wan.On this basis, by being progressively separated the method that Liuwei Dihuang Wan chemical composition and vitro enzyme determination of activity combine, find and identify a kind of new pharmacological component-glucaric acid Isosorbide-5-Nitrae lactone in Liuwei Dihuang Wan.Literature research (Charles B.S., Journal of Orthomolecular Medicine Vol. 16, No. 2,2001) show that this material (comprising its precursor glucarate) has and comprise anticancer and that estrogen is relevant pharmacological action widely, before, this compound does not have the report be found in Chinese herbal medicine, therefore, does not have glucarate and lactone thereof at the report of Chinese herbal medicine content assaying method.
Although glucarate is found to be present in fruit as in apple and grape and a small amount of vegetables, up to now, has no and utilize HPLC-HILIC-UV/ELSD and HPLC-MS/MS technology to carry out the report of quantitative measurement to them.
Summary of the invention
Fundamental purpose of the present invention applies multiple separation detection technique such as HPLC-HILIC-UV/ELSD/MS to the new discovery component sugar glucose diacid salt in six drugs containing rehmanniae preparation series and glucaric acid Isosorbide-5-Nitrae lactone to carry out quantitative test.
Glucarate and glucaric acid Isosorbide-5-Nitrae lactone structure formula as follows:
Concrete scheme of the present invention is as follows:
Take a certain amount of Liuwei Dihuang preparation, add 60% methanol solution of certain volume, ultrasonic 20min, centrifugal, precipitation is extracted once with the above-mentioned solution of equal-volume again, centrifugal, merges supernatant; Gained supernatant is directly analyzed by MS or HPLC-MS technology; Glucarate characteristic molecular negative ion quasi-molecular ions is 209,191,85; Glucaric acid Isosorbide-5-Nitrae lactone characteristic molecular negative ion quasi-molecular ions is 191,85; Chromatographic retention, mass spectrogram are consistent with standard items.
Glucarate and glucaric acid Isosorbide-5-Nitrae lactone content assay method in Liuwei Dihuang preparation, comprising:
1) glucarate and glucaric acid 1, the preparation of 4 lactone standard solution: precision takes glucarate and glucaric acid 1 respectively, 4 lactone two kinds reference substance 40.0mg, quantitatively be transferred in 10.0mL volumetric flask, thin up is to scale, and precision pipettes in 5.0mL to 10.0mL volumetric flask, adds 80% dilution in acetonitrile to scale, be mixed with 200.0ug/mL solution, in contrast product mother solution;
2) HPLC-HILIC-UV/ELSD method measures the content of total glucarate in Liuwei Dihuang Wan:
Get Liuwei Dihuang Wan, pulverize, precision takes 500mg, adds 4Ml 2-5%Na 2cO 3the ultrasonic 20min of solution, centrifugal, precipitation is extracted once with the above-mentioned solution of equal-volume again, centrifugal, merges supernatant; Adopt the little column extracting of C18 SPE, collect 5% methanol-eluted fractions, with the 55 DEG C of dryings of high-speed vacuum centrifugal drier, dry thing accurately adds 1.0mL 80% acetonitrile, 10,000 leaves heart 10min gets supernatant and carries out HPLC-HILIC-UV/ELSD analysis, carries out quantitatively with calibration curve method to glucarate; HPLC-HILIC-UV method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC, internal diameter 4.6mm, granularity 5um; With acetonitrile-5mM ammonium dihydrogen phosphate (ADP) for mobile phase, both volume ratios are 78:22 perseverance degree wash-out; Flow velocity 0.8mL/min; Determined wavelength 205nm; Sample introduction 10ul, column temperature 30 DEG C; HPLC-HILIC-ELSD method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC ZIC-HILIC, internal diameter 4.6mm, granularity 5um; Be eluent gradient wash-out with acetonitrile A phase-0.02% Ammoniom-Acetate B phase: 0-5min A phase 80%, 5-25min A phase 80%-75%, 25-30min A phase is 75%-50%, 30-35min A phase is 50%-80%; Flow velocity 0.8mL/min; Sample introduction 10ul, drift tube temperature 60 DEG C of air-flow 1.2L/min;
3) in Liuwei Dihuang Wan, glucaric acid Isosorbide-5-Nitrae lactone content measures:
Get Liuwei Dihuang Wan, pulverize, precision takes 500mg, add 4.0 mL 60% methanol solutions, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, and residue continues to add 4.0mL 60% methanol solution, ultrasonic 20min, 5,, 000 leaves heart 10min gets supernatant, merges supernatant, 14,000 to leave after the heart suitably dilution sample introduction UPLC-MS/MS analyzes; Chromatographic condition: Waters BEH C18 chromatographic column, long 50mm, internal diameter 1.0 mm, particle diameter 1.7um, column temperature: 40 DEG C; Mobile phase: A phase is 10mM formic acid, B phase is acetonitrile; Flow velocity 0.4mL/min; Mass Spectrometry Conditions: Negative electrospray ionization source ESI-, voltage 2000V, source temp 100 DEG C, taper hole voltage 15V, desolventizing temperature degree 300 DEG C, taper hole gas and desolventizing airshed are respectively 50 and 600L/min; Full scan pattern 50 ~ 1200amu; Secondary collision energy 15V; The intensity of the fragment peak 85 of molecular ion peak 191 is used for the quantitative of glucose 1.4-lactone; Carry out quantitatively with calibration curve method to glucaric acid Isosorbide-5-Nitrae lactone;
4) in Liuwei Dihuang Wan, glucarate and glucaric acid Isosorbide-5-Nitrae lactone detect simultaneously:
Get Liuwei Dihuang Wan, pulverize, precision takes 500mg, add 4.0 mL 60% methanol solutions, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, and residue continues to add 4.0mL 60% methanol solution, ultrasonic 20min, 5,, 000 leaves heart 10min gets supernatant, merges supernatant, 14,000 to leave after the heart suitably dilution sample introduction HPLC-LILIC-UV analyzes; HPLC-HILIC-UV method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC, internal diameter 4.6mm, granularity 5um; With acetonitrile A phase-5mM ammonium dihydrogen phosphate (ADP)+1.0% phosphoric acid B phase for mobile phase, eluent gradient elution program: 0-3min A phase 83%, 3-15min A phase 83-65%, 15-18min A phase 65%, 18-20min A phase 65-83%, 20-30min A phase 83%; Determined wavelength 205nm; Sample introduction 10ul, column temperature 30 DEG C; With calibration curve method, simultaneous quantitative is carried out to glucarate and glucaric acid Isosorbide-5-Nitrae lactone.
Described Na 2cO 3solution concentration is preferably 2.0%.
The invention has the beneficial effects as follows: in view of the new discovery component sugar glucose diacid salt in six drugs containing rehmanniae preparation series and glucaric acid 1,4 lactones have clear and definite action target spot and pharmacological action widely, and the present invention applies the quality control, effective substance research etc. that the quantitative analysis method of multiple separation detection technique as HPLC-HILIC-UV/ELSD/MS contributes to six drugs containing rehmanniae preparation series.
Accompanying drawing explanation
Fig. 1 HPLC-HILIC-UV method measures total glucarate chromatogram in Liuwei Dihuang Wan
A: glucaric acid potassium standard items chromatogram.B: Liuwei Dihuang Wan 2.0%Na2CO3 extract chromatogram.
Fig. 2 HPLC-HILIC-ELSD method measures total glucarate chromatogram in Liuwei Dihuang Wan
A: Liuwei Dihuang Wan 2.0%Na2CO3 extract chromatogram.B: glucaric acid potassium standard items chromatogram.
Fig. 3 UPLC-MS/MS method measures glucaric acid Isosorbide-5-Nitrae lactone chromatogram in Liuwei Dihuang Wan
A: glucaric acid Isosorbide-5-Nitrae lactone standard items chromatogram.B: Liuwei Dihuang Wan 60% methanol extract liquid chromatogram.
Glucarate and glucaric acid Isosorbide-5-Nitrae lactone chromatogram in Fig. 4 HPLC-HILIC-UV method Simultaneously test Liuwei Dihuang Wan
A: Liuwei Dihuang Wan 60% methanol extract liquid adds glucaric acid potassium and glucaric acid Isosorbide-5-Nitrae lactone standard items chromatogram.B: Liuwei Dihuang Wan 60% methanol extract liquid chromatogram.C: glucaric acid potassium and glucaric acid Isosorbide-5-Nitrae lactone standard items chromatogram.
Embodiment
embodiment 1
HPLC-HILIC-UV/ELSD method measures the content of total glucarate in Liuwei Dihuang Wan
1) glucaric acid Isosorbide-5-Nitrae lactone changes into glucarate
Respectively with the Na of variable concentrations 2cO 3solubilize preparation glucaric acid Isosorbide-5-Nitrae lactone standard items, HPLC-HILIC-UV analyzes, and determines that glucaric acid Isosorbide-5-Nitrae lactone is converted into the condition of glucarate completely.The Na of result display 2.0% 2cO 3solution can make glucaric acid Isosorbide-5-Nitrae lactone be converted into glucarate completely completely.
2) assay
Get Liuwei Dihuang Wan (Beijing Tongrentang, condensed pill), pulverize, precision takes 500mg, adds 4.0Ml 2% Na 2cO 3the ultrasonic 20min of solution, centrifugal, precipitation is extracted once with the above-mentioned solution of equal-volume again, centrifugal, merges supernatant; Adopt C18 SPE little column extracting, collect 5% methanol-eluted fractions, with the 55 DEG C of dryings of high-speed vacuum centrifugal drier, dry thing accurately adds 1.0mL 80% acetonitrile, and 10,000 leaves heart 10min gets supernatant and carry out HPLC-HILIC-UV/ELSD analysis.
HPLC-HILIC-UV method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC, internal diameter 4.6mm, granularity 5um.With acetonitrile-5mM ammonium dihydrogen phosphate (ADP) for mobile phase, both volume ratios are 78:22 perseverance degree wash-out.Flow velocity 0.8mL/min; Determined wavelength 205nm; Sample introduction 10ul, column temperature 30 DEG C.Typical color spectrogram is as Fig. 1 .record in three batches of Liuwei Dihuang Wans (condensed pill, Beijing Tongrentang) containing total glucarate be 8.0-10.0mg/g.
HPLC-HILIC-ELSD method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC ZIC-HILIC, internal diameter 4.6mm, granularity 5um.With acetonitrile (A)-0.02% Ammoniom-Acetate (B) for eluent gradient wash-out: 0-5min A phase 80%, 5-25min A phase 80%-75%, 25-30min A phase is 75%-50%, 30-35min A phase is 50%-80%.Flow velocity 0.8mL/min; Sample introduction 10ul, drift tube temperature 60 DEG C of air-flow 1.2L/min. typical color spectrogram is as Fig. 2.record in three batches of Liuwei Dihuang Wans (condensed pill, Beijing Tongrentang) containing total glucarate be 8.6-11.2mg/g.
embodiment 2
UPLC-MS/MS method measures the content of glucose 1.4-lactone in Liuwei Dihuang Wan
Get Liuwei Dihuang Wan (Beijing Tongrentang, condensed pill), pulverize, precision takes 500mg, adds 4.0 mL 60% methanol solutions, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, and residue continues to add 4.0mL 60% methanol solution, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, merge supernatant, 14,000 to leave after the heart suitably dilution sample introduction UPLC-MS/MS analyzes.
Chromatographic condition: Waters BEH C18 chromatographic column, long 50mm, internal diameter 1.0 mm, particle diameter 1.7um, column temperature: 40 DEG C.Mobile phase: A phase is 10mM formic acid, B phase is acetonitrile; Flow velocity 0.4mL/min.Mass Spectrometry Conditions: Negative electrospray ionization source (ESI-), voltage 2000V, source temp 100 DEG C, taper hole voltage 15V, desolventizing temperature degree 300 DEG C, taper hole gas and desolventizing airshed are respectively 50 and 600L/min.Full scan pattern (50 ~ 1200amu).Secondary collision energy 15V.The intensity of the fragment peak 85 of molecular ion peak 191 is used for the quantitative of glucose 1.4-lactone.With calibration curve method, glucaric acid Isosorbide-5-Nitrae lactone is carried out quantitatively.Typical color spectrogram is as Fig. 3. this method record in 3 batches of Liuwei Dihuang Wans (condensed pill, Beijing Tongrentang) containing glucaric acid Isosorbide-5-Nitrae lactone be 3.5-5.0mg/g.
embodiment 3
The content of glucarate and glucose 1.4-lactone in HPLC-LILIC-UV method Simultaneously test Liuwei Dihuang Wan
Get Liuwei Dihuang Wan (Beijing Tongrentang, condensed pill), pulverize, precision takes 500mg, adds 4.0 mL 60% methanol solutions, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, and residue continues to add 4.0mL 60% methanol solution, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, merge supernatant, 14,000 to leave after the heart suitably dilution sample introduction HPLC-LILIC-UV analyzes.
HPLC-HILIC-UV method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC, internal diameter 4.6mm, granularity 5um.With acetonitrile (A)-5mM ammonium dihydrogen phosphate (ADP)+1.0% phosphoric acid (B) for mobile phase, eluent gradient elution program: 0-3min A phase 83%, 3-15min A phase 83-65%, 15-18min A phase 65%, 18-20min A phase 65-83%, 20-30min A phase 83%.Determined wavelength 205nm; Sample introduction 10ul, column temperature 30 DEG C.Typical color spectrogram is as Fig. 4.With calibration curve method, glucarate and glucaric acid Isosorbide-5-Nitrae lactone are carried out quantitatively.Record in 3 batches of Liuwei Dihuang Wans (condensed pill, Beijing Tongrentang) and contain total glucarate at 2.0-4.8mg/g, containing glucaric acid Isosorbide-5-Nitrae lactone at 4.0-6.5mg/g.
The glucarate that the present invention sets up and (or) glucaric acid Isosorbide-5-Nitrae lactone quantitative detecting method meets the requirement of Chinese Pharmacopoeia (2010 editions) to chromatographic fractionation system adaptability, accuracy, linear relationship and precision.
The above is only the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, without departing from the inventive concept of the premise; can also make some improvements and modifications, these improvements and modifications also should be considered within the scope of protection of the present invention.

Claims (2)

1. glucarate and glucaric acid 1 in Liuwei Dihuang preparation, 4 lactone content assay methods, it is characterized in that comprising: 1) glucarate and glucaric acid 1, the preparation of 4 lactone standard solution: precision takes glucarate and glucaric acid 1 respectively, 4 lactone two kinds reference substance 40.0mg, quantitatively be transferred in 10.0mL volumetric flask, thin up is to scale, precision pipettes in 5.0mL to 10.0mL volumetric flask, add 80% dilution in acetonitrile to scale, be mixed with 200.0 μ g/mL solution, in contrast product mother solutions;
2) HPLC-HILIC-UV/ELSD method measures the content of total glucarate in Liuwei Dihuang Wan:
Get Liuwei Dihuang Wan, pulverize, precision takes 500mg, adds 4.0mL 2-5%Na 2cO 3the ultrasonic 20min of solution, centrifugal, precipitation is extracted once with the above-mentioned solution of equal-volume again, centrifugal, merges supernatant; Adopt the little column extracting of C18 SPE, collect 5% methanol-eluted fractions, centrifugal with high-speed vacuum, dryer 55 DEG C of dryings, dry thing accurately adds 1.0mL 80% acetonitrile, 10,000 leaves heart 10min gets supernatant and carries out HPLC-HILIC-UV/ELSD analysis, carries out quantitatively with calibration curve method to glucarate; HPLC-HILIC-UV method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC, internal diameter 4.6mm, granularity 5 μm; With acetonitrile-5mM ammonium dihydrogen phosphate (ADP) for mobile phase, both volume ratios are 78:22 perseverance degree wash-out; Flow velocity 0.8mL/min; Determined wavelength 205nm; Sample introduction 10 μ l, column temperature 30 DEG C; HPLC-HILIC-ELSD method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC ZIC-HILIC, internal diameter 4.6mm, granularity 5 μm; Be eluent gradient wash-out with acetonitrile A phase-0.02% Ammoniom-Acetate B phase: 0-5min A phase 80%, 5-25min A phase 80%-75%, 25-30min A phase is 75%-50%, 30-35min A phase is 50%-80%; Flow velocity 0.8mL/min; Sample introduction 10 μ l, drift tube temperature 60 DEG C, air-flow 1.2L/min;
3) in Liuwei Dihuang Wan, glucaric acid Isosorbide-5-Nitrae lactone content measures:
Get Liuwei Dihuang Wan, pulverize, precision takes 500mg, add 4.0 mL 60% methanol solutions, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, residue continues to add 4.0mL 60% methanol solution, ultrasonic 20min, 5000 leave heart 10min gets supernatant, merges supernatant, 14,000 to leave after the heart suitably dilution sample introduction UPLC-MS/MS analyzes; Chromatographic condition: Waters BEH C18 chromatographic column, long 50mm, internal diameter 1.0 mm, particle diameter 1.7 μm, column temperature: 40 DEG C; Mobile phase: A phase is 10mM formic acid, B phase is acetonitrile; Flow velocity 0.4mL/min; Mass Spectrometry Conditions: Negative electrospray ionization source ESI-, voltage 2000V, source temp 100 DEG C, taper hole voltage 15V, desolventizing temperature degree 300 DEG C, taper hole gas and desolventizing airshed are respectively 50 and 600L/min; Full scan pattern 50 ~ 1200amu; Secondary collision energy 15V; The intensity of the fragment peak 85 of molecular ion peak 191 is used for the quantitative of glucose 1.4-lactone; Carry out quantitatively with calibration curve method to glucaric acid Isosorbide-5-Nitrae lactone;
4) in Liuwei Dihuang Wan, glucarate and glucaric acid Isosorbide-5-Nitrae lactone detect simultaneously:
Get Liuwei Dihuang Wan, pulverize, precision takes 500mg, add 4.0 mL 60% methanol solutions, ultrasonic 20min, 5,000 leaves heart 10min gets supernatant, residue continues to add 4.0mL 60% methanol solution, ultrasonic 20min, 5000 leave heart 10min gets supernatant, merges supernatant, 14,000 to leave after the heart suitably dilution sample introduction HPLC-LILIC-UV analyzes; HPLC-HILIC-UV method chromatographic condition: chromatographic column is the long 250mm of ZIC-HILIC, internal diameter 4.6mm, granularity 5 μm; With acetonitrile A phase-5mM ammonium dihydrogen phosphate (ADP)+1.0% phosphoric acid B phase for mobile phase, eluent gradient elution program: 0-3min A phase 83%, 3-15min A phase 83-65%, 15-18min A phase 65%, 18-20min A phase 65-83%, 20-30min A phase 83%; Determined wavelength 205nm; Sample introduction 10 μ l, column temperature 30 DEG C; With calibration curve method, simultaneous quantitative is carried out to glucarate and glucaric acid Isosorbide-5-Nitrae lactone.
2. method as claimed in claim 1, is characterized in that described Na 2cO 3solution concentration is 2.0%.
CN201310431091.XA 2013-09-22 2013-09-22 Determination method of contents of saccharate and saccharic acid 1,4-lactone in Liuwei Dihuang preparations Active CN103698416B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310431091.XA CN103698416B (en) 2013-09-22 2013-09-22 Determination method of contents of saccharate and saccharic acid 1,4-lactone in Liuwei Dihuang preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310431091.XA CN103698416B (en) 2013-09-22 2013-09-22 Determination method of contents of saccharate and saccharic acid 1,4-lactone in Liuwei Dihuang preparations

Publications (2)

Publication Number Publication Date
CN103698416A CN103698416A (en) 2014-04-02
CN103698416B true CN103698416B (en) 2014-12-31

Family

ID=50360015

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310431091.XA Active CN103698416B (en) 2013-09-22 2013-09-22 Determination method of contents of saccharate and saccharic acid 1,4-lactone in Liuwei Dihuang preparations

Country Status (1)

Country Link
CN (1) CN103698416B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546205A (en) * 1967-04-06 1970-12-08 Chugai Pharmaceutical Co Ltd Stabilizing method and the preparation stabilized thereby
CN102590370A (en) * 2012-01-16 2012-07-18 南京林业大学 Method for synchronously determining monosaccharide, uronic acid and saccharic acid in wood fiber material reaction system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10310562A (en) * 1997-03-13 1998-11-24 Tosoh Corp Production of benzylamine salts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546205A (en) * 1967-04-06 1970-12-08 Chugai Pharmaceutical Co Ltd Stabilizing method and the preparation stabilized thereby
CN102590370A (en) * 2012-01-16 2012-07-18 南京林业大学 Method for synchronously determining monosaccharide, uronic acid and saccharic acid in wood fiber material reaction system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Elucidation of the Structures of Metabolites of Picroside II in Rat Bile by LC–ESI–IT–MS;Tingting Li 等;《Chromatographia》;20110630;第73卷(第11-12期);第1111-1120页 *
六味地黄丸中24-乙酰泽泻醇A含量的高效液相色谱法测定;高军秀 等;《时珍国医国药》;20101031;第21卷(第10期);第2694-2695页 *
川贝母和其它贝母中β-D-葡萄糖4-1β-D-半乳糖和蔗糖含量的HPLC-ELSD 测定;陈阳 等;《时珍国医国药》;20120731;第23卷(第7期);第1605-1606页 *
营养成分对红茶菌液中D-葡萄糖二酸-1,4-内酯和总酸含量的影响;王侃 等;《食品与发酵工业》;20070630;第33卷(第6期);第24-27页 *

Also Published As

Publication number Publication date
CN103698416A (en) 2014-04-02

Similar Documents

Publication Publication Date Title
Duan et al. LC–MS/MS determination and pharmacokinetic study of five flavone components after solvent extraction/acid hydrolysis in rat plasma after oral administration of Verbena officinalis L. extract
Li et al. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen)
CN102539553B (en) Method for establishing fingerprint spectrum of liver-enhancing medicine
CN108508107B (en) Method for simultaneously determining effective components of Xuebijing injection in blood plasma
CN105259268B (en) The detection method and its application of flavonoids and organic acid ingredients fingerprint in a kind of Bilobanoate
He et al. The discovery of Q-markers of Qiliqiangxin Capsule, a traditional Chinese medicine prescription in the treatment of chronic heart failure, based on a novel strategy of multi-dimensional “radar chart” mode evaluation
CN105467059A (en) Quality detecting method for traditional Chinese medicine composition for treating hematuresis
Sun et al. Exploring potential biomarkers of coronary heart disease treated by Jing Zhi Guan Xin Pian using high-throughput metabolomics
Chang et al. Simultaneous determination of four phenolic acids and seven alkaloids in rat plasma after oral administration of traditional Chinese medicinal preparation Jinqi Jiangtang Tablet by LC-ESI–MS/MS
CN101685089B (en) Method for quickly quality-detecting and identifying American ginsengs, ginsengs and preparations of American ginsengs and ginsengs
Jung et al. Simultaneous determination of puerarin and its active metabolite in human plasma by UPLC-MS/MS: Application to a pharmacokinetic study
Tu et al. Advances in analytical techniques and quality control of traditional Chinese medicine injections
CN104101674B (en) A kind of method of screening Yinchenhao Tang, Oriental Wormwood Decoction effective substance
CN104914199A (en) Determining method for contents of twelve components in traditional Chinese medicine composition preparation
Lee et al. Quality control of Pulsatilla koreana based on the simultaneous determination of triterpenoidal saponins by HPLC‐ELSD and principal component analysis
Wang et al. Recent advances in separation and analysis of saponins in natural products
Ning et al. A single marker choice strategy in simultaneous characterization and quantification of multiple components by rapid resolution liquid chromatography coupled with triple quadrupole tandem mass spectrometry (RRLC-QqQ-MS)
CN107449846B (en) Method for measuring effective components in infantile nerve-soothing and brain-nourishing granules by HPLC-MS (high Performance liquid chromatography-Mass Spectrometry)
Qiu et al. Limitation standard of toxic aconitines in Aconitum proprietary Chinese medicines using on-line extraction electrospray ionization mass spectrometry
Zhao et al. Quality control method of sterols in fermented Cordyceps sinensis based on combined fingerprint and quantitative analysis of multicomponents by single marker
Zhang et al. Simultaneous quantification of five steroid saponins from Dioscorea zingiberensis CH Wright in rat plasma by HPLC–MS/MS and its application to the pharmacokinetic studies
Wang et al. Simultaneous determination of six hydrophilic components in rat plasma after oral administration of Jitai tablet by liquid chromatography–electrospray ionization–tandem mass spectrometry: Application to a pharmacokinetic study
He et al. Application of a liquid chromatography–tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion in the study of anemoside B4, a novel antiviral agent candidate, in rats
Yuan et al. Simultaneous determination of four active compounds in Centella asiatica by supramolecular solvent-based extraction coupled with high performance liquid chromatography-tandem mass spectrometry
CN111721880A (en) Method for establishing fingerprint of sarcandra glabra by using double-column tandem HPLC-MS

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20171221

Address after: 342500 Jiangxi province Ruijin economic and Technological Development Zone Jinlong two road innovation and entrepreneurial incubator base

Patentee after: Ruijin Hongdu Industrial Investment Development Co. Ltd.

Address before: 999 No. 330031 Jiangxi province Nanchang Honggutan University Avenue

Patentee before: Nanchang University

CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 342500 innovation and entrepreneurship incubation base, Jinlong Second Road, Ruijin economic and Technological Development Zone, Ganzhou City, Jiangxi Province

Patentee after: Ruijin Industrial Investment Development Co., Ltd

Address before: 342500 Jiangxi province Ruijin economic and Technological Development Zone Jinlong two road innovation and entrepreneurial incubator base

Patentee before: Ruijin Hongdu Industrial Investment Development Co. Ltd.